Publicacións en colaboración con investigadores/as de Hospital Morales Meseguer (49)

2024

  1. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

    Breast Cancer Research and Treatment, Vol. 206, Núm. 2, pp. 317-328

2023

  1. Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols

    HemaSphere

2021

  1. Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)

    Leukemia Research, Vol. 109

  2. Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia

    Blood, Vol. 137, Núm. 14, pp. 1879-1894

  3. Comparative study of formaldehyde 2% in aqueous solution vs TRUE Test in detecting formaldehyde sensitization

    Contact Dermatitis, Vol. 85, Núm. 3, pp. 358-359

  4. Coronavirus confinement: A chance to learn on oral cancer—The Spanish experience

    Oral Diseases

  5. Early clinical experience with trifluridine/tipiracil for refractory metastatic colorectal cancer: The ros study

    Cancers, Vol. 13, Núm. 18

  6. Epidemiological, Clinical, and Allergy Profile of Patients With Atopic Dermatitis and Hand Eczema: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC)

    Actas Dermo-Sifiliograficas

  7. European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis

    Contact Dermatitis, Vol. 85, Núm. 2, pp. 186-197

  8. Gingival exophytic lesions as first oral manifestation of primary lung adenocarcinomas: Systematic review

    National Journal of Maxillofacial Surgery, Vol. 12, Núm. 3, pp. 297-302

  9. Role of artificial intelligence in the early diagnosis of oral cancer. A scoping review

    Cancers, Vol. 13, Núm. 18

2020

  1. A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial

    Cancer Medicine, Vol. 9, Núm. 7, pp. 2317-2329

  2. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial

    The Lancet Respiratory Medicine, Vol. 8, Núm. 3, pp. 267-276

  3. Efficiency in patch testing: the number needed to test to get one relevant result as a new approach in the evaluation of baseline series

    British Journal of Dermatology

  4. Is p-Phenylenediamine Still a Prevalent Contact Allergen in Spain?

    Actas Dermo-Sifiliograficas, Vol. 111, Núm. 1, pp. 47-52

  5. Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 20, Núm. 8, pp. e513-e522

  6. Trend of relevant contact allergens of the feet in Spain over a period of 10 years

    Contact Dermatitis, Vol. 82, Núm. 4, pp. 211-217

  7. Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia

    Haematologica

2019

  1. AZATAX: Acetazolamide safety and efficacy in cerebellar syndrome in PMM2 congenital disorder of glycosylation (PMM2-CDG)

    Annals of Neurology, Vol. 85, Núm. 5, pp. 740-751

  2. European Surveillance System on Contact Allergies (ESSCA): Contact allergies in relation to body sites in patients with allergic contact dermatitis

    Contact Dermatitis, Vol. 80, Núm. 5, pp. 263-272